Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000726531 | SCV000701562 | pathogenic | not provided | 2018-01-12 | criteria provided, single submitter | clinical testing | |
Counsyl | RCV000594511 | SCV000790900 | likely pathogenic | Autosomal recessive limb-girdle muscular dystrophy type 2A | 2018-05-15 | criteria provided, single submitter | clinical testing | |
Revvity Omics, |
RCV000726531 | SCV002018065 | pathogenic | not provided | 2019-07-13 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000594511 | SCV002227607 | pathogenic | Autosomal recessive limb-girdle muscular dystrophy type 2A | 2023-05-12 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 497201). This premature translational stop signal has been observed in individual(s) with clinical features of autosomal recessive CAPN3-related conditions (PMID: 31671740). This variant is present in population databases (no rsID available, gnomAD 0.006%). This sequence change creates a premature translational stop signal (p.Asp764Thrfs*12) in the CAPN3 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in CAPN3 are known to be pathogenic (PMID: 10330340, 15689361). |